2-piperidone has been researched along with B16 Melanoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pfeffer, LM; Sims, M; Yang, CH; Yue, J | 1 |
Fofaria, NM; Liu, X; Qhattal, HS; Srivastava, SK | 1 |
Hamada, M; Homma, Y; Imoto, M; Nakae, K; Sawa, T; Takeuchi, T; Yoshimoto, Y | 1 |
3 other study(ies) available for 2-piperidone and B16 Melanoma
Article | Year |
---|---|
The curcumin analog EF24 targets NF-κB and miRNA-21, and has potent anticancer activity in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Cell Line, Tumor; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; MicroRNAs; Piperidones; Prostatic Neoplasms; RNA Interference; Signal Transduction; Transcription Factor RelA; Xenograft Model Antitumor Assays | 2013 |
Nanoemulsion formulations for anti-cancer agent piplartine--Characterization, toxicological, pharmacokinetics and efficacy studies.
Topics: Animals; Antineoplastic Agents, Phytogenic; Caco-2 Cells; Chemistry, Pharmaceutical; Emulsions; Female; Humans; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanoparticles; Piperidones; Treatment Outcome; Xenograft Model Antitumor Assays | 2016 |
Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities.
Topics: Animals; Antibiotics, Antineoplastic; Cell Movement; Cell Survival; Chemotaxis; DNA; Drug Screening Assays, Antitumor; Esophageal Neoplasms; Fermentation; Humans; Lactones; Macrolides; Melanoma, Experimental; Mice; Neoplasms; Piperidones; Protein Biosynthesis; RNA; Streptomyces; Tumor Cells, Cultured; Wound Healing | 2000 |